Navigation Links
Berger & Montague Announces Class Action Lawsuit Against Elan Corporation
Date:10/29/2008

PHILADELPHIA, Oct. 29 /PRNewswire-USNewswire/ -- Berger & Montague ("Berger") announced today that a class action lawsuit was filed in the United States District Court of New York on behalf of all purchasers of American Depository Shares (evidenced by American Depository Receipts) of Elan Corporation PLC ("elan" or the "Company") and all purchasers of options to purchase Elan securities during the period of June 17, 2008 through July 29, 2008 (the "Class Period") charging Elan and certain of its principal officers and directors with violations of the federal securities laws.

The complaint alleges that the Defendants materially misrepresented the facts about the results of a clinical study of a four ascending doses of a drug (bapineuzumab or AAB-001) that the Company and Wyeth were testing as a treatment for mild to moderate Alzheimer's disease.

The complaint alleges that the Defendants issued materially false and misleading representations stating that the 18 month clinical study of AAB-001, the Elan-Wyeth drug, produced "statistically significant and clinically meaningful benefits" in the 40-70% of patients with mild to moderate Alzheimer's disease who do not carry the gene that predisposes a person to Alzheimer's disease, as measured by four neuropsychological, mental and other Alzheimer's disease assessment scales.

These representations were materially misleading due to the facts disclosed at a medical conference on July 29, 2008, as follows:

(a) Typically, if a drug is effective higher doses of a drug correspond with increased efficacy. In the study of AAB-001 that did not occur. Indeed, patients did not even show a consistent pattern of benefit across the four different dosages that were administered in the trial.

(b) The lowest doses of AAB-001 worked better on some measures of cognition and function, while higher doses worked better on others, and sometimes doses in the middle produced worse results than placebo. This
'/>"/>

SOURCE Berger & Montague, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
2. Nationally Recognized Information Technology Veteran and Entrepreneur John Bamberger Joins gloStream, Inc. as Chief Channel Officer
3. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
4. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
5. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
6. HEI, Inc. Announces Sale of RFID Division Assets
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
9. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
10. Brooke Franchise Corporation Announces Selected July Results
11. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... NC (PRWEB) , ... June 30, 2015 , ... ... Virginia” title in a recent online poll at http://scoutology.com/novaburgerwars and was selected ... to be published in August 2015. , Red Hot & Blue President Randy McCann ...
(Date:6/30/2015)... ... ... New Energy Works Timberframers invites the public to join their timber frame ... beam raisings offer a chance to witness the culmination of months of planning, designing, ... and exciting event – it is an age-old craft where the bones of the ...
(Date:6/30/2015)... (PRWEB) , ... June 30, ... ... CorrectChemo®, the drug response profiling test to help oncologists provide personalized cancer ... , “The CorrectChemo® assay provides the oncologist with valuable insight on how ...
(Date:6/30/2015)... NJ (PRWEB) , ... June 30, 2015 , ... NJ ... On May 13th, she hosted a CPR Course for members of the Bergen ... members can get updated on the latest CPR recommendations for Healthcare Providers. Life ...
(Date:6/30/2015)... ... June 30, 2015 , ... Eldermark Software shakes up ... the senior care sector. As an innovator of senior care software ... more efficient and offer residents better care. , This next-generation interactive system handles ...
Breaking Medicine News(10 mins):Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 2Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 3Health News:Join New Energy Works Timberframers in Raising the Frames in Western New York 4Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 2Health News:Correct Chemo Joins NextGxDx Online Genetic Testing Marketplace 3Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 2Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 3Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 3
... A new poll of AARP members released today finds ... health care reform included in the Affordable Health Care for ... The AARP-backed bill limits how much more insurance companies can ... drug doughnut hole. , Among AARP members, strong majorities ...
... KUNMING, China, Nov. 16 /PRNewswire-Asia-FirstCall/ -- ... Shenghuo" or,the "Company"), which is engaged in the research, ... products,in the People,s Republic of China ("PRC"), today reported ... 2009. , , Third Quarter 2009 ...
... steer clear of low-fat meal plans, study says , ... may work better than a low-fat regimen for people ... them at higher risk for cardiovascular disease, new research ... confirms that the current recommendations are appropriate," said Alice ...
... the normal cells that surround cancer cells within and ... increase the effectiveness of traditional anti-cancer treatments, say researchers ... of Clinical Investigation published online November 16, they ... expressed by one type of these so-called "stromal" cells, ...
... to improve diagnosis and monitoring of Alzheimer,s disease, scientists ... a fast and accurate method for quantifying subtle, sub-regional ... study will be published the week of November 16 ... Sciences ( PNAS ). By applying the ...
... If cost-cutting U.S. Preventive Services Task Force ... decades of decline in breast cancer mortality could ... needlessly from breast cancer each year. The recommendations ... no medical imaging representation ─ would advise against ...
Cached Medicine News:Health News:Survey Finds AARP Members Back Health Care Reform Legislation 2Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 2Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 3Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 4Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 5Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 6Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 7Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 8Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 9Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 10Health News:China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 2009 11Health News:Moderate-Fat Diet May Be Better at Reducing Heart Risks 2Health News:Moderate-Fat Diet May Be Better at Reducing Heart Risks 3Health News:Wistar researchers show targeting 'normal' cells in tumors slows growth 2Health News:Wistar researchers show targeting 'normal' cells in tumors slows growth 3Health News:Analyzing structural brain changes in Alzheimer's disease 2Health News:USPSTF mammography recommendations will result in countless unnecessary breast cancer deaths each year 2Health News:USPSTF mammography recommendations will result in countless unnecessary breast cancer deaths each year 3
(Date:6/30/2015)... June 30, 2015 Zynerba Pharmaceuticals, Inc. today announced ... with the U.S. Securities and Exchange Commission (SEC) relating to ... number of shares to be offered and the price range ... Jefferies LLC and Piper Jaffray & Co. will ... Genuity Inc. and Oppenheimer & Co. Inc. will act as ...
(Date:6/30/2015)... June 30, 2015 A new analysis ... exposure to high-priced Hepatitis C medications could range ... percent of Californians infected with Hepatitis C receive treatment through ... of new Hepatitis C treatments on public programs, comes at ... price tags for drugs like Gilead Sciences, Harvoni and Sovaldi. ...
(Date:6/30/2015)...  Today, the National Mobility Equipment Dealers Association (NMEDA) ... Awareness Month Local Heroes Contest on National TV. The ... received 1.3 million votes. The sponsors for the wheelchair ... , and Valley Honda Dealers , with the ... Mobility International (VMI) and ElDorado Mobility .  ...
Breaking Medicine Technology:Zynerba Files Registration Statement for Proposed Initial Public Offering of Common Stock 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 2New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 3New Analysis Reveals High-Priced Hepatitis C Drugs Could Have Costly Impact on State 4NMEDA Announces National Contest Winners 2NMEDA Announces National Contest Winners 3
... with West Nile Virus and populations ... PURCHASE, N.Y., Sept. 9 A recently ... by the Division of,Vector-Borne Infectious Diseases with the ... that AHCC(R) (Active Hexose Correlated,Compound) enhances host resistance ...
... Epiphany Biosciences, Inc. today,announced that a Phase 2b ... of the company,s lead compound, valomaciclovir,(EPB-348) in patients ... originally designed following an interim analysis., Fred ... with the,progress of this clinical trial and look ...
Cached Medicine Technology:Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus 2Study Demonstrates That AHCC(R) Provides Immune Enhancement Against the West Nile Virus 3Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN) 2
The Protract stem offers a press-fit option which will allow choice of standard or lateralized neck offsets while keeping a consistent leg length....
M2 cemented hip stem....
Cemented foundation 450 series....
A cementless femoral stem that promotes bone in-growth and reduces thigh pain....
Medicine Products: